ModraDoc006/r vs Docetaxel IV in Metastatic Prostate Cancer

Clinical trial NCT04028388 · COMPLETED

Trial details

NCT number: NCT04028388
Sponsor: Modra Pharmaceuticals
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Prostate Cancer Metastatic Castration-resistant Prostate Cancer

Start date: 2019-07-17
Primary completion: 2021-11-29
Enrollment: 135

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.